Skip to main content
. 2022 Jul 20:jfac058. doi: 10.1093/jalm/jfac058

Table 2.

Published sensitivity and specificity of RSV tests by assay technology in all included studies.

RSV tests with analytical time ≤30 min (n = 88) RSV tests with analytical time >30 min (n = 45)
Method Antigen Molecular Molecular
Subrecords, n (%) 61 (69.3) 27 (30.7) 41 (91.1)a
Overall
 Sensitivity, % 25.7–100 66.7–100 62.5–100
 Specificity, % 80.3–100 94.3–100 77.0–100
Age
 <18 years
  Sensitivity, % 25.7–97.6 84.3–100 74.3–100
  Specificity, % 80.3–100 94.3–100 97.8–100
 ≥18 yearsb
  Sensitivity, % 62.5–100
  Specificity, % 98.9–100
 Mixed age
  Sensitivity, % 57.5–100 77.8–100 63.2–100
  Specificity, % 91.8–100 94.7–100 77.0–100
Setting
 Inpatient
  Sensitivity, % 25.7–95.2 98.1–100 80.4–100
  Specificity, % 80.3–100 94.3–99.4 91.5–100
 Emergency department/outpatient
  Sensitivity, % 67.8–97.6 93–100 62.5–100
  Specificity, % 97.6–99.6 96–100 97.8–100
a

The mariPOC Respi test (n = 4 subrecords) was included in the RSV tests with analytical time >30 min category as the final result is available after 2 h. The sensitivity and specificity values were not included in the table as there were insufficient data to produce a range of sensitivity or specificity values for relevant patient and setting characteristics.

b

Only 1 study assessed an RSV test with analytical time ≤30 min in an adult-only (≥18 years) population; therefore, it was not possible to produce a range of sensitivity or specificity values.